Table 1.
Patient demographics
| Characteristics | Values |
|---|---|
| Age (years), median (range) | 65 (32–85) |
| Male gender, n (%) | 418 (78.7) |
| Patients with coexisting disease, n (%) | |
| COPD | 36 (6.8) |
| Hypertension | 131 (24.7) |
| Diabetes | 28 (5.3) |
| Heart disease | 13 (2.5) |
| Location of lesion, n (%) | |
| Central airways | 87 (16.4) |
| Peripheral bronchi | 444 (83.6) |
| Histologic types, n (%) | |
| Adenocarcinoma | 141 (26.6) |
| Squamous cell carcinoma | 268 (50.5) |
| SCLC | 100 (18.8) |
| NSCLC (not specified) | 6 (1.1) |
| Neuroendocrine carcinoma | 4 (0.8) |
| Adenosquamous carcinoma | 5 (0.9) |
| Adenoid cystic carcinoma | 1 (0.2) |
| Histology not specified | 6 (1.1) |
| Stage, n (%) | |
| Early | 313 (59.0) |
| Advanced | 218 (41.0) |
| Biopsy-induced bleeding, n (%) | 162 (30.5) |
| Methods of hemostasis, n (%) | |
| Single cold water application | 81 (50.0) |
| Combined application (cold water, adrenalin or/and APC) | 81 (50.0) |
Abbreviations: APC, argon plasma coagulation; NSCLC, non-small-cell lung carcinoma; SCLC, small-cell lung carcinoma.